opioid receptor, kappa 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| immune response | ||
| phospholipase C-activating G protein-coupled receptor signaling pathway | ||
| neuropeptide signaling pathway | ||
| locomotory behavior | ||
| locomotory behavior |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| membrane | ||
| membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| G protein-coupled opioid receptor activity | ||
| G protein-coupled opioid receptor activity | ||
| protein binding | ||
| receptor serine/threonine kinase binding | ||
| dynorphin receptor activity |
| Location | References |
|---|---|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060001 | withdrawal disorder | |
| DOID:5844 | myocardial infarction | |
| DOID:9976 | heroin dependence |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026